Since NK cells efficiently recognize and kill tumor cells bearing NKG2D ligands, a reduction of MICB on the tumor surface potentially inhibits the “danger signals” that alerts the innate immune system, and therefore reduces tumor elimination. The gene discussed is KLRK1; the disease is neoplasm.